Inovio Pharmaceuticals Inc. $(INO)$ is set to present at the Orphan Drug Summit in Boston, Massachusetts, on July 16. The biotechnology company will discuss the potential of next generation DNA medicine technology in rare diseases during their presentation titled "DMAb Technology: The Transformational Potential of Next Gen DNA Medicine in Rare Disease."
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.